You are here: Home » News-CM » Companies » Results
Business Standard

Lincoln Pharmaceuticals consolidated net profit declines 21.16% in the June 2019 quarter

Capital Market 

Sales decline 3.02% to Rs 96.81 crore

Net profit of Lincoln Pharmaceuticals declined 21.16% to Rs 12.67 crore in the quarter ended June 2019 as against Rs 16.07 crore during the previous quarter ended June 2018. Sales declined 3.02% to Rs 96.81 crore in the quarter ended June 2019 as against Rs 99.82 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales96.8199.82 -3 OPM %19.6823.33 -PBDT19.7024.26 -19 PBT17.8522.68 -21 NP12.6716.07 -21

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, August 16 2019. 10:25 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU